Jump to content
RemedySpot.com

Re: FW: NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for Youth

Rate this topic


Guest guest

Recommended Posts

Believe me Mark they have already seen it. M. Faenza, President and CEO

of NMHA, is a pawn of a $37B machine called big pharma. The FDA wants more time

to study the data while kids are dying. This is what they asked for back in

1991. It's too bad didn't report what really happened at the FDA

meeting. Maybe he fell asleep at the meeting or didn't read any significant

newspaper like the NY Times the next day or both.

Mark Heyrman <mheyrman@...> wrote:

see below

hope you will circulate this to your friends

Makr

NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for

Youth

NMHA Statement to the Media

February 2, 2004

NMHA Lauds FDA Safety Review of Antidepressants for Youth

Calls for Attention to Public Health Crisis of Untreated Mental Disorders in

Children

A Statement by M. Faenza, President and CEO of NMHA

Contact:

Cobb

703-797-2588

hcobb@...

ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health Association

commends the Food and Drug Administration for initiating a review today of the

clinical use of antidepressant medications in youth. More scientific research is

needed on the safety of all medications prescribed to children. Traditionally,

very little research has been done on children and medications - including those

commonly used to treat physical illnesses. Yet, there is no question that SSRIs,

like medications used to treat physical disease, are crucial in treating serious

and potentially life-threatening illnesses.

The safety issue is not one to be ignored. However, we cannot let the discussion

about antidepressant medication overshadow the public health crisis of untreated

mental disorders in children. In this nation, only one-third of children needing

mental health treatment receive it, and even fewer receive appropriate care.

Depression alone affects one in 33 children and one in eight adolescents. By

failing to provide appropriate treatments and interventions to children with

mental or emotional disorders, we risk harming their social and educational

development, which can lead to academic failure, substance abuse problems or

involvement in the juvenile justice system. In fact, 80 percent of young people

in the juvenile justice system have a mental or substance abuse disorder,

according to a report of the President's New Freedom Commission on Mental

Health.

Parents of children with mental health problems face incredible barriers to

getting needed treatment, including fragmented service systems, primary care

providers who lack specialized training, too few pediatric mental health

specialists, insurance obstacles in both public and private plans, a lack of

quality school programs and trained personnel, complex policies obstructing

access to needed treatment, including medications, and - perhaps the worst of

all - stigma.

The stigma surrounding mental illness is an enormous factor limiting families'

ability to obtain effective services. Misinformation dissuades parents from

seeking proven treatments for their children. And stigma and lack of information

contribute to the misperception that we are " drugging our children. " In reality,

children and their families need access to a broad range of services, which for

some children may include medication.

We call on FDA to guard against overreaction. We urge that the needs and best

interests of children not be swept aside by shrill calls - some from those who

deny that mental illness even exists - for sweeping action that would deprive

children of access to treatment and support.

NMHA believes that the approach to antidepressant medications for youth with

major depressive disorder must be measured. We must ensure that treatments for

children are safe and effective through increased research and the sharing of

all clinical findings. And we must be mindful of the many, many children with

mental health needs who benefit greatly from these medications.

The National Mental Health Association is the country's oldest and largest

nonprofit organization addressing all aspects of mental health and mental

illness. With more than 340 affiliates nationwide, NMHA works to improve the

mental health of all Americans through advocacy, education, research and

service.

###

F. Prior jprior@... Chicago, IL 60656-1639

Calendar: http://calendar./j_prior

Cell: 773/230-5825 Fax: 781/459-8592

: 22:36-40

Link to comment
Share on other sites

Believe me Mark they have already seen it. M. Faenza, President and CEO

of NMHA, is a pawn of a $37B machine called big pharma. The FDA wants more time

to study the data while kids are dying. This is what they asked for back in

1991. It's too bad didn't report what really happened at the FDA

meeting. Maybe he fell asleep at the meeting or didn't read any significant

newspaper like the NY Times the next day or both.

Mark Heyrman <mheyrman@...> wrote:

see below

hope you will circulate this to your friends

Makr

NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for

Youth

NMHA Statement to the Media

February 2, 2004

NMHA Lauds FDA Safety Review of Antidepressants for Youth

Calls for Attention to Public Health Crisis of Untreated Mental Disorders in

Children

A Statement by M. Faenza, President and CEO of NMHA

Contact:

Cobb

703-797-2588

hcobb@...

ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health Association

commends the Food and Drug Administration for initiating a review today of the

clinical use of antidepressant medications in youth. More scientific research is

needed on the safety of all medications prescribed to children. Traditionally,

very little research has been done on children and medications - including those

commonly used to treat physical illnesses. Yet, there is no question that SSRIs,

like medications used to treat physical disease, are crucial in treating serious

and potentially life-threatening illnesses.

The safety issue is not one to be ignored. However, we cannot let the discussion

about antidepressant medication overshadow the public health crisis of untreated

mental disorders in children. In this nation, only one-third of children needing

mental health treatment receive it, and even fewer receive appropriate care.

Depression alone affects one in 33 children and one in eight adolescents. By

failing to provide appropriate treatments and interventions to children with

mental or emotional disorders, we risk harming their social and educational

development, which can lead to academic failure, substance abuse problems or

involvement in the juvenile justice system. In fact, 80 percent of young people

in the juvenile justice system have a mental or substance abuse disorder,

according to a report of the President's New Freedom Commission on Mental

Health.

Parents of children with mental health problems face incredible barriers to

getting needed treatment, including fragmented service systems, primary care

providers who lack specialized training, too few pediatric mental health

specialists, insurance obstacles in both public and private plans, a lack of

quality school programs and trained personnel, complex policies obstructing

access to needed treatment, including medications, and - perhaps the worst of

all - stigma.

The stigma surrounding mental illness is an enormous factor limiting families'

ability to obtain effective services. Misinformation dissuades parents from

seeking proven treatments for their children. And stigma and lack of information

contribute to the misperception that we are " drugging our children. " In reality,

children and their families need access to a broad range of services, which for

some children may include medication.

We call on FDA to guard against overreaction. We urge that the needs and best

interests of children not be swept aside by shrill calls - some from those who

deny that mental illness even exists - for sweeping action that would deprive

children of access to treatment and support.

NMHA believes that the approach to antidepressant medications for youth with

major depressive disorder must be measured. We must ensure that treatments for

children are safe and effective through increased research and the sharing of

all clinical findings. And we must be mindful of the many, many children with

mental health needs who benefit greatly from these medications.

The National Mental Health Association is the country's oldest and largest

nonprofit organization addressing all aspects of mental health and mental

illness. With more than 340 affiliates nationwide, NMHA works to improve the

mental health of all Americans through advocacy, education, research and

service.

###

F. Prior jprior@... Chicago, IL 60656-1639

Calendar: http://calendar./j_prior

Cell: 773/230-5825 Fax: 781/459-8592

: 22:36-40

Link to comment
Share on other sites

All this concern about the children getting treatment and yet no

mention that the drug companies studies have consistently found that

the safest, most effective treatment for depression is the placebo.

Maybe if they came up with a medication that actually worked.......

>

> see below

> hope you will circulate this to your friends

> Makr

>

> NMHA Statement: NMHA Lauds FDA Safety Review of

Antidepressants for Youth

>

>

>

> NMHA Statement to the Media

> February 2, 2004

>

>

>

> NMHA Lauds FDA Safety Review of Antidepressants for Youth

> Calls for Attention to Public Health Crisis of Untreated Mental

Disorders in Children

>

> A Statement by M. Faenza, President and CEO of NMHA

>

>

>

> Contact:

>

> Cobb

> 703-797-2588

> hcobb@n...

>

>

> ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health

Association commends the Food and Drug Administration for initiating a

review today of the clinical use of antidepressant medications in

youth. More scientific research is needed on the safety of all

medications prescribed to children. Traditionally, very little

research has been done on children and medications - including those

commonly used to treat physical illnesses. Yet, there is no question

that SSRIs, like medications used to treat physical disease, are

crucial in treating serious and potentially life-threatening

illnesses.

>

> The safety issue is not one to be ignored. However, we cannot let

the discussion about antidepressant medication overshadow the public

health crisis of untreated mental disorders in children. In this

nation, only one-third of children needing mental health treatment

receive it, and even fewer receive appropriate care.

>

> Depression alone affects one in 33 children and one in eight

adolescents. By failing to provide appropriate treatments and

interventions to children with mental or emotional disorders, we risk

harming their social and educational development, which can lead to

academic failure, substance abuse problems or involvement in the

juvenile justice system. In fact, 80 percent of young people in the

juvenile justice system have a mental or substance abuse disorder,

according to a report of the President's New Freedom Commission on

Mental Health.

>

> Parents of children with mental health problems face incredible

barriers to getting needed treatment, including fragmented service

systems, primary care providers who lack specialized training, too few

pediatric mental health specialists, insurance obstacles in both

public and private plans, a lack of quality school programs and

trained personnel, complex policies obstructing access to needed

treatment, including medications, and - perhaps the worst of all -

stigma.

>

> The stigma surrounding mental illness is an enormous factor limiting

families' ability to obtain effective services. Misinformation

dissuades parents from seeking proven treatments for their children.

And stigma and lack of information contribute to the misperception

that we are " drugging our children. " In reality, children and their

families need access to a broad range of services, which for some

children may include medication.

>

> We call on FDA to guard against overreaction. We urge that the needs

and best interests of children not be swept aside by shrill calls -

some from those who deny that mental illness even exists - for

sweeping action that would deprive children of access to treatment and

support.

>

> NMHA believes that the approach to antidepressant medications for

youth with major depressive disorder must be measured. We must ensure

that treatments for children are safe and effective through increased

research and the sharing of all clinical findings. And we must be

mindful of the many, many children with mental health needs who

benefit greatly from these medications.

>

> The National Mental Health Association is the country's oldest and

largest nonprofit organization addressing all aspects of mental health

and mental illness. With more than 340 affiliates nationwide, NMHA

works to improve the mental health of all Americans through advocacy,

education, research and service.

>

> ###

>

>

>

>

> F. Prior jprior@w... Chicago, IL 60656-1639

>

> Calendar: http://calendar./j_prior

>

> Cell: 773/230-5825 Fax: 781/459-8592

>

> : 22:36-40

>

>

>

>

>

>

Link to comment
Share on other sites

All this concern about the children getting treatment and yet no

mention that the drug companies studies have consistently found that

the safest, most effective treatment for depression is the placebo.

Maybe if they came up with a medication that actually worked.......

>

> see below

> hope you will circulate this to your friends

> Makr

>

> NMHA Statement: NMHA Lauds FDA Safety Review of

Antidepressants for Youth

>

>

>

> NMHA Statement to the Media

> February 2, 2004

>

>

>

> NMHA Lauds FDA Safety Review of Antidepressants for Youth

> Calls for Attention to Public Health Crisis of Untreated Mental

Disorders in Children

>

> A Statement by M. Faenza, President and CEO of NMHA

>

>

>

> Contact:

>

> Cobb

> 703-797-2588

> hcobb@n...

>

>

> ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health

Association commends the Food and Drug Administration for initiating a

review today of the clinical use of antidepressant medications in

youth. More scientific research is needed on the safety of all

medications prescribed to children. Traditionally, very little

research has been done on children and medications - including those

commonly used to treat physical illnesses. Yet, there is no question

that SSRIs, like medications used to treat physical disease, are

crucial in treating serious and potentially life-threatening

illnesses.

>

> The safety issue is not one to be ignored. However, we cannot let

the discussion about antidepressant medication overshadow the public

health crisis of untreated mental disorders in children. In this

nation, only one-third of children needing mental health treatment

receive it, and even fewer receive appropriate care.

>

> Depression alone affects one in 33 children and one in eight

adolescents. By failing to provide appropriate treatments and

interventions to children with mental or emotional disorders, we risk

harming their social and educational development, which can lead to

academic failure, substance abuse problems or involvement in the

juvenile justice system. In fact, 80 percent of young people in the

juvenile justice system have a mental or substance abuse disorder,

according to a report of the President's New Freedom Commission on

Mental Health.

>

> Parents of children with mental health problems face incredible

barriers to getting needed treatment, including fragmented service

systems, primary care providers who lack specialized training, too few

pediatric mental health specialists, insurance obstacles in both

public and private plans, a lack of quality school programs and

trained personnel, complex policies obstructing access to needed

treatment, including medications, and - perhaps the worst of all -

stigma.

>

> The stigma surrounding mental illness is an enormous factor limiting

families' ability to obtain effective services. Misinformation

dissuades parents from seeking proven treatments for their children.

And stigma and lack of information contribute to the misperception

that we are " drugging our children. " In reality, children and their

families need access to a broad range of services, which for some

children may include medication.

>

> We call on FDA to guard against overreaction. We urge that the needs

and best interests of children not be swept aside by shrill calls -

some from those who deny that mental illness even exists - for

sweeping action that would deprive children of access to treatment and

support.

>

> NMHA believes that the approach to antidepressant medications for

youth with major depressive disorder must be measured. We must ensure

that treatments for children are safe and effective through increased

research and the sharing of all clinical findings. And we must be

mindful of the many, many children with mental health needs who

benefit greatly from these medications.

>

> The National Mental Health Association is the country's oldest and

largest nonprofit organization addressing all aspects of mental health

and mental illness. With more than 340 affiliates nationwide, NMHA

works to improve the mental health of all Americans through advocacy,

education, research and service.

>

> ###

>

>

>

>

> F. Prior jprior@w... Chicago, IL 60656-1639

>

> Calendar: http://calendar./j_prior

>

> Cell: 773/230-5825 Fax: 781/459-8592

>

> : 22:36-40

>

>

>

>

>

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...